Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain.
about
HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain.Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathyAttenuation of myogenic orofacial nociception and mechanical hypersensitivity by viral mediated enkephalin overproduction in male and female ratsSpinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways.Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalinGene transfer of glutamic acid decarboxylase reduces neuropathic pain.HSV delivery of a ligand-regulated endogenous ion channel gene to sensory neurons results in pain control following channel activation.Relief of pain induced by varicella-zoster virus in a rat model of post-herpetic neuralgia using a herpes simplex virus vector expressing enkephalin.Gene therapy for pain: results of a phase I clinical trial.Injury-specific promoters enhance herpes simplex virus-mediated gene therapy for treating neuropathic pain in rodentsDevelopment of viral vectors for gene therapy for chronic painExploiting the neurotherapeutic potential of peptides: targeted delivery using HSV vectors.Current gene therapy using viral vectors for chronic painHerpes simplex virus-based vectors.Vector-mediated release of GABA attenuates pain-related behaviors and reduces Na(V)1.7 in DRG neurons.Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociceptionThe therapeutic potential of gene transfer for the treatment of peripheral neuropathies.HSV vector-mediated GAD67 suppresses neuropathic pain induced by perineural HIV gp120 in rats through inhibition of ROS and Wnt5aViral vector-based gene transfer for treatment of chronic pain.Gene therapy applications for the treatment of neuropathic pain.Herpes vector-mediated gene transfer in the treatment of chronic painApplications of gene therapy to the treatment of chronic pain.Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNF alpha.A human trial of HSV-mediated gene transfer for the treatment of chronic pain.HSV gene transfer in the treatment of chronic pain.Herpes simplex virus vector-mediated gene delivery for the treatment of lower urinary tract pain.Gene therapy for pancreatitis pain.HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain.A clinical trial of gene therapy for chronic pain.Targeted biological therapies for pain.Targeted drug delivery to the peripheral nervous system using gene therapy.Gene therapy for the treatment of chronic peripheral nervous system pain.Progress in gene therapy for neurological disorders.Herpes simplex virus-based nerve targeting gene therapy in pain management.Herpes simplex viral vectors: late bloomers with big potential.Gene therapy: a potential approach for cancer pain.Modulating pain in the periphery: gene-based therapies to enhance peripheral opioid analgesia: Bonica lecture, ASRA 2010.Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification.Efficient delivery of RNA Interference to peripheral neurons in vivo using herpes simplex virus.Lumbar transplantation of immortalized enkephalin-expressing astrocytes attenuates chronic neuropathic pain.
P2860
Q25257395-4A063F98-590D-443E-838C-D805B953B7C8Q28580927-C832653A-0804-449F-A738-7D3667306797Q30630884-E325E04F-3821-4CB6-95F5-2233897D6992Q33640240-BE59CEC0-0403-48DB-9A91-7687194AE5DEQ33792025-133B2D65-7BED-490C-BDF8-183E0FF79049Q34062737-0FC4AB61-360A-4CD3-BAD2-5C2181A0F508Q34621676-1404C5CE-77A7-4717-9F44-DF03CDC876F2Q35073428-8B254B0D-D4B2-442D-9DD1-3DC16550DFF1Q35154100-2539F2DB-51BE-4AFE-8590-D74311FB1861Q35155806-0B6CF82E-E1DB-418D-8B5A-E5AFE98DC963Q35430864-FE1DDD78-AFFF-4798-A67D-ECD3D3A84C7BQ35594068-8192E9B1-0A2B-4860-BFD5-7444F4F3EC38Q35658521-652DBBCE-AEA9-46A8-9EFD-606D3EB2FF4AQ35863367-9EE74E31-DD83-444E-91AC-B3C8B2F0270BQ35875239-CC78DFC3-856E-43E1-A0EF-41372B1C0905Q36634794-526F2289-9EE7-4E00-8FB4-3FE97F7E1E38Q36762639-E55E6354-927C-4BDD-9359-8A571AD64D8DQ36777541-6EBA5AEE-9F8A-4B4B-AFEE-9C5ED565D644Q36787828-A1FD509B-AC11-44B4-99F8-D645C5AE3EE2Q36817045-26B5BCDD-6888-4F59-9097-727FDC45D44FQ37035292-DD53D9C3-28F6-43A1-BC37-64AB64F8833DQ37108334-C74E98E9-C043-483B-A160-09E03C98A9FCQ37134881-CA89B895-2046-426B-8458-C97D058589ACQ37195741-E3A08F57-82C6-480A-878B-190537622894Q37310900-3BFE3557-8E31-45F3-8C8B-71AAA9E905BBQ37320394-E1579DE8-0E6E-4B95-9428-1E1E2D69C862Q37406982-82BFED44-B064-4483-B351-8957E175D628Q37439341-2B27989C-73D1-4850-8682-C27FE24F8026Q37612033-F686351D-7ACD-45C4-BE8D-60B49780A5CFQ37882724-B5F92416-8303-49D5-BAEA-1364A0A839F1Q38008125-5BD0F519-313D-4975-9D8C-95ABA955FC3BQ38016275-886096A8-84DD-46A7-97E9-556DB3A601E3Q38100997-141F8900-81D0-4237-A842-F20925572A2DQ38182564-CC175522-23D0-41B5-B6CD-76D82C5B1C6AQ38185694-8272AA25-B1EA-49F8-9F7E-8B06ABB84008Q38745962-111958CD-A9FB-4E41-93D6-F68E4E794053Q39673255-5CB57BE1-46A7-4F1A-9826-BF0404D40771Q39756417-2BA0FF6F-934A-487F-916F-0A127DA1FAF4Q39967822-D303C454-93F1-44F0-8E4F-8A79174CAB0EQ40074575-516E91B0-A4C8-438C-B0B8-C62253E7D552
P2860
Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Transgene-mediated enkephalin ...... ic effect in neuropathic pain.
@en
Transgene-mediated enkephalin ...... ic effect in neuropathic pain.
@nl
type
label
Transgene-mediated enkephalin ...... ic effect in neuropathic pain.
@en
Transgene-mediated enkephalin ...... ic effect in neuropathic pain.
@nl
prefLabel
Transgene-mediated enkephalin ...... ic effect in neuropathic pain.
@en
Transgene-mediated enkephalin ...... ic effect in neuropathic pain.
@nl
P2093
P1433
P1476
Transgene-mediated enkephalin ...... ic effect in neuropathic pain.
@en
P2093
David J Fink
Joseph C Glorioso
Marina Mata
Shuanglin Hao
William Goins
P304
P356
10.1016/S0304-3959(02)00346-9
P407
P577
2003-03-01T00:00:00Z